Patents by Inventor Corey Hopkins

Corey Hopkins has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TRPC5 inhibitors and methods of using same
    Patent number: 11370769
    Abstract: Provided herein are TRPC5 inhibitors and methods of using the same, e.g., to protect podocytes and/or treat kidney disease.
    Type: Grant
    Filed: September 7, 2018
    Date of Patent: June 28, 2022
    Assignees: Board of Regents of the University of Nebraska, The Brigham and Women's Hospital, Inc.
    Inventors: Corey Hopkins, Anna Greka
  • Phosphodiesterase inhibitors
    Patent number: 11180499
    Abstract: Provided herein are compounds and methods for modulating the phosphodiesterase PDE4. More particularly, provided are selective inhibitors PDE4 and the uses of such inhibitors in regulating diseases and disorders, e.g., to treat cancer, inflammatory diseases, neurological diseases, neurodegenerative diseases, and addiction.
    Type: Grant
    Filed: April 12, 2021
    Date of Patent: November 23, 2021
    Assignee: BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA
    Inventor: Corey Hopkins
  • PHOSPHODIESTERASE INHIBITORS
    Publication number: 20210230160
    Abstract: Provided herein are compounds and methods for modulating the phosphodiesterase PDE4. More particularly, provided are selective inhibitors PDE4 and the uses of such inhibitors in regulating diseases and disorders, e.g., to treat cancer, inflammatory diseases, neurological diseases, neurodegenerative diseases, and addiction.
    Type: Application
    Filed: April 12, 2021
    Publication date: July 29, 2021
    Inventor: Corey Hopkins
  • TRPC5 INHIBITORS AND METHODS OF USING SAME
    Publication number: 20200216411
    Abstract: Provided herein are TRPC5 inhibitors and methods of using the same, e.g., to protect podocytes and/or treat kidney disease.
    Type: Application
    Filed: September 7, 2018
    Publication date: July 9, 2020
    Inventors: Corey Hopkins, Anna Greka
  • Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders
    Patent number: 7132428
    Abstract: Compounds of the formula I are suitable for producing pharmaceuticals for the prophylaxis and therapy of diseases whose course involves an increased activity of NIK.
    Type: Grant
    Filed: July 3, 2003
    Date of Patent: November 7, 2006
    Assignee: Aventis Pharmaceuticals Inc.
    Inventors: Tahir Nadeem Majid, Corey Hopkins, Brian Leslie Pedgrift, Nicola Collar, Friederike Wirtz-Brugger, Jean Merrill
  • Pyrazoloisoquinoline derivative as kinase inhibitors for the treatment of various disorders
    Publication number: 20050009859
    Abstract: Compounds of the formula I are suitable for producing pharmaceuticals for the prophylaxis and therapy of diseases whose course involves an increased activity of NIK.
    Type: Application
    Filed: July 3, 2003
    Publication date: January 13, 2005
    Applicant: Aventis Pharmaceuticals Inc.
    Inventors: Tahir Majid, Corey Hopkins, Brian Pedgrift, Nicola Collar, Friederike Wirtz-Brugger, Jean Merrill